Author pages are created from data sourced from our academic publisher partnerships and public sources.
Diagnostic criteria for multiple sclerosis: 2010 Revisions to the McDonald criteria
New evidence and consensus has led to further revision of the McDonald Criteria for diagnosis of multiple sclerosis. The use of imaging for demonstration of dissemination of central nervous system… Expand
Diagnostic criteria for multiple sclerosis: 2005 revisions to the “McDonald Criteria”
New diagnostic criteria for multiple sclerosis integrating magnetic resonance image assessment with clinical and other paraclinical methods were introduced in 2001. The “McDonald Criteria” have been… Expand
A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis
BACKGROUND Neuromyelitis optica is an inflammatory demyelinating disease with generally poor prognosis that selectively targets optic nerves and spinal cord. It is commonly misdiagnosed as multiple… Expand
The clinical course of neuromyelitis optica (Devic’s syndrome)
Objectives: To evaluate the spectrum of neuromyelitis optica (NMO), including characteristics of the index events (optic neuritis [ON]) and myelitis), neuroimaging, CSF, and serologic studies, and to… Expand
The spectrum of neuromyelitis optica
- D. Wingerchuk, V. Lennon, C. Lucchinetti, S. Pittock, B. Weinshenker
- The Lancet Neurology
- 1 September 2007
Neuromyelitis optica (also known as Devic's disease) is an idiopathic, severe, demyelinating disease of the central nervous system that preferentially affects the optic nerve and spinal cord.… Expand
International consensus diagnostic criteria for neuromyelitis optica spectrum disorders
Neuromyelitis optica (NMO) is an inflammatory CNS syndrome distinct from multiple sclerosis (MS) that is associated with serum aquaporin-4 immunoglobulin G antibodies (AQP4-IgG). Prior NMO diagnostic… Expand
Revised diagnostic criteria for neuromyelitis optica
Background: The authors previously proposed diagnostic criteria for neuromyelitis optica (NMO) that facilitate its distinction from prototypic multiple sclerosis (MS). However, some patients with… Expand
Revised diagnostic criteria for neuromyelitis optica.
BACKGROUND The authors previously proposed diagnostic criteria for neuromyelitis optica (NMO) that facilitate its distinction from prototypic multiple sclerosis (MS). However, some patients with… Expand
Development of a multiple sclerosis functional composite as a clinical trial outcome measure.
The primary clinical outcome measure for evaluating multiple sclerosis in clinical trials has been Kurtzke's expanded disability status scale (EDSS). New therapies appear to favourably impact the… Expand